BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 10656876)

  • 1. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
    Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
    Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
    Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
    Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
    Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
    Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival.
    Imai M; Takigami K; Guckelberger O; Kaczmarek E; Csizmadia E; Bach FH; Robson SC
    Transplantation; 2000 Sep; 70(6):864-70. PubMed ID: 11014639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the imbalance in B cell-expressed nucleoside triphosphate diphosphohydrolase 1-induced ADP degradation in graft injury during acute antibody-mediated rejection.
    Zhang Y; Wang Y; Zong H; Yang C
    Transpl Immunol; 2012 Dec; 27(4):175-8. PubMed ID: 22885372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury.
    Köhler D; Eckle T; Faigle M; Grenz A; Mittelbronn M; Laucher S; Hart ML; Robson SC; Müller CE; Eltzschig HK
    Circulation; 2007 Oct; 116(16):1784-94. PubMed ID: 17909107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.
    Enjyoji K; Sévigny J; Lin Y; Frenette PS; Christie PD; Esch JS; Imai M; Edelberg JM; Rayburn H; Lech M; Beeler DL; Csizmadia E; Wagner DD; Robson SC; Rosenberg RD
    Nat Med; 1999 Sep; 5(9):1010-7. PubMed ID: 10470077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD39 modulates endothelial cell activation and apoptosis.
    Goepfert C; Imai M; Brouard S; Csizmadia E; Kaczmarek E; Robson SC
    Mol Med; 2000 Jul; 6(7):591-603. PubMed ID: 10997340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD39/vascular ATP diphosphohydrolase modulates xenograft survival.
    Imai M; Takigami K; Guckelberger O; Lin Y; Sevigny J; Kaczmarek E; Goepfert C; Enjyoji K; Bach FH; Rosenberg RD; Robson SC
    Transplant Proc; 2000 Aug; 32(5):969. PubMed ID: 10936301
    [No Abstract]   [Full Text] [Related]  

  • 10. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.
    Dwyer KM; Robson SC; Nandurkar HH; Campbell DJ; Gock H; Murray-Segal LJ; Fisicaro N; Mysore TB; Kaczmarek E; Cowan PJ; d'Apice AJ
    J Clin Invest; 2004 May; 113(10):1440-6. PubMed ID: 15146241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting platelet aggregation: CD39 gene transfer augments nucleoside triphosphate diphosphohydrolase activity in injured rabbit arteries.
    Gangadharan SP; Imai M; Rhynhart KK; Sévigny J; Robson SC; Conte MS
    Surgery; 2001 Aug; 130(2):296-303. PubMed ID: 11490363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty.
    Koziak K; Bojakowska M; Robson SC; Bojakowski K; Soin J; Csizmadia E; Religa P; Gaciong Z; Kaczmarek E
    J Thromb Haemost; 2008 Jul; 6(7):1191-7. PubMed ID: 18485080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Nucleoside Triphosphate Diphosphohydrolase-1-Associated Imbalance in Adenosine Diphosphate Degradation, B-Cell Activation, and Related Injury During Acute Antibody-Mediated Rejection.
    Wang X; Zhang Y; Wei G; Li Z; Tian D; Huang W
    Transplant Proc; 2018 Jun; 50(5):1292-1297. PubMed ID: 29880349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
    Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transgenic expression of human CD39 on murine islets inhibits clotting of human blood.
    Dwyer KM; Mysore TB; Crikis S; Robson SC; Nandurkar H; Cowan PJ; D'Apice AJ
    Transplantation; 2006 Aug; 82(3):428-32. PubMed ID: 16906044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain.
    Braun N; Sévigny J; Robson SC; Enjyoji K; Guckelberger O; Hammer K; Di Virgilio F; Zimmermann H
    Eur J Neurosci; 2000 Dec; 12(12):4357-66. PubMed ID: 11122346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes.
    Leal DB; Streher CA; Neu TN; Bittencourt FP; Leal CA; da Silva JE; Morsch VM; Schetinger MR
    Biochim Biophys Acta; 2005 Jan; 1721(1-3):9-15. PubMed ID: 15652174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disordered cellular migration and angiogenesis in cd39-null mice.
    Goepfert C; Sundberg C; Sévigny J; Enjyoji K; Hoshi T; Csizmadia E; Robson S
    Circulation; 2001 Dec; 104(25):3109-15. PubMed ID: 11748109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD39 modulates IL-1 release from activated endothelial cells.
    Imai M; Goepfert C; Kaczmarek E; Robson SC
    Biochem Biophys Res Commun; 2000 Apr; 270(1):272-8. PubMed ID: 10733939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness.
    Mizumoto N; Kumamoto T; Robson SC; Sévigny J; Matsue H; Enjyoji K; Takashima A
    Nat Med; 2002 Apr; 8(4):358-65. PubMed ID: 11927941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.